FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have intensified their oversight of the cannabis industry, issuing another round of warning letters to companies on Tuesday. The businesses are accused of selling products infused with hemp-derived cannabinoids, such as delta-8 THC, in packaging deceptively resembling popular children’s snacks.
This move marks the second consecutive year of such actions, signaling a tightening grip on deceptive marketing practices.
FTC Targets Deceptive THC Edibles Marketing
“Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk,” Samuel Levine, director of FTC’s Bureau of Consumer Protection stated in a press release. As Hemp Today notes, this regulatory spotlight aligns with concerns over delta-8 THC, delta-10 THC, THC-O-acetate, HHC, THCP, and hemp-derived THCA – substances gaining notoriety for their psychoactive effects yet slipping through legislative cracks.